Tag: Mohamad Mohty

MaaT Pharma doses first patient in HERACLES phase 2 trial of MaaT013

pharmanewsdaily- October 13, 2018

MaaT Pharma,a French oncology company, said that it has dosed the first patient in the HERACLES phase 2 trial of MaaT013, a microbiome restoration candidate, in ... Read More